Royston, United Kingdom

Emanuela Gancia

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Emanuela Gancia. Retrieved from https://idiyas.com/inventor/emanuela-gancia-gpivl8kv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Inventor Emanuela Gancia

Introduction:

Inventor Emanuela Gancia hails from Royston, GB, and is known for his groundbreaking work in the field of pharmacology. With multiple patents to his name, Emanuela is a driving force behind advancements in the treatment of central nervous system (CNS) disorders.

Latest Patents:

Emanuela Gancia holds a significant patent for compounds of formula (I) that act as potent and selective 5-HT antagonists. These compounds have shown promise in the treatment of various adverse conditions of the CNS, showcasing Emanuela's ingenuity and dedication to improving healthcare.

Career Highlights:

Emanuela Gancia is a valued member of the Merck Sharp & Dohme Corporation, where his expertise and innovative thinking have contributed to the development of cutting-edge pharmaceutical solutions. His keen understanding of pharmacological principles has enabled him to make significant strides in the field.

Collaborations:

Throughout his career, Emanuela Gancia has collaborated with esteemed professionals such as Mark Stewart Chambers and Neil Roy Curtis. These collaborations have sparked new ideas, fostered creativity, and led to impactful developments in pharmacology.

Conclusion:

Inventor Emanuela Gancia's relentless pursuit of innovation and his profound contributions to the field of pharmacology make him a standout figure in the realm of healthcare advancements. His patents and collaborations serve as testaments to his remarkable talent and dedication to improving the lives of individuals affected by CNS disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…